4
Registered trials
0
Recruiting
1
Unique sponsors
2
Unique IMPs
4
Commercial trials
Drug classes (ATC)
—
ATC code not specified
3
B
Haematology (ATC B)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
1 substance
Factor Xa inhibitor (DOAC)
1 substance
Phase III:
2
Phase I (Other):
2
Phase III
2 trials-
EndedBayer AG CommercialASUNDEXIAN
-
EndedBayer AG CommercialAPIXABAN; ASUNDEXIAN
Phase I (Other)
2 trials-
EndedBayer AG CommercialIMP not specified
-
EndedBayer AG CommercialIMP not specified
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Bayer AG | Commercial | 4 | Phase I (Other), Phase III | 0 |
New trials by year
2022
1
2023
1
2024
2